George V. Migausky, Director at Immunovant, Inc. (IMVT), bought 7,000 shares at $7.65 ($54K) on 2021-08-20, disclosed to the SEC on 2021-08-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| DYAX | SELL | 2015-03-06 | $79K | — | Filing → |
| DYAX | SELL | 2015-02-26 | $141K | — | Filing → |
| DYAX | SELL | 2014-06-17 | $132K | — | Filing → |